Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect.

Levine MS, Cepeda C, Hickey MA, Fleming SM, Chesselet MF.

Trends Neurosci. 2004 Nov;27(11):691-7. Review.

PMID:
15474170
2.

Transgenic mouse models of Parkinson's disease and Huntington's disease.

Skaper SD, Giusti P.

CNS Neurol Disord Drug Targets. 2010 Aug;9(4):455-70. Review.

PMID:
20522011
3.

The use of stem cells in regenerative medicine for Parkinson's and Huntington's Diseases.

Lescaudron L, Naveilhan P, Neveu I.

Curr Med Chem. 2012;19(35):6018-35. Review.

PMID:
22963567
4.

Animal models of Alzheimer's Parkinson's and Huntington's disease. A minireview.

Antal A, Bodis-Wollner I.

Neurobiology (Bp). 1993;1(2):101-22. Review.

PMID:
8111350
5.

Neurodegenerative disorders: Parkinson's disease and Huntington's disease.

Hague SM, Klaffke S, Bandmann O.

J Neurol Neurosurg Psychiatry. 2005 Aug;76(8):1058-63. Review.

6.

Of molecular interactions, mice and mechanisms: new insights into Huntington's disease.

Wellington CL, Hayden MR.

Curr Opin Neurol. 1997 Aug;10(4):291-8. Review.

PMID:
9266152
7.

Animal models of Huntington's disease.

Gárdián G.

Ideggyogy Sz. 2006 Nov 20;59(11-12):396-9. Review.

PMID:
17203874
8.

Applications of lentiviral vectors for biology and gene therapy of neurological disorders.

Lundberg C, Björklund T, Carlsson T, Jakobsson J, Hantraye P, Déglon N, Kirik D.

Curr Gene Ther. 2008 Dec;8(6):461-73. Review.

PMID:
19075629
9.

Molecular genetics of Huntington's disease.

Gusella JF, MacDonald ME, Ambrose CM, Duyao MP.

Arch Neurol. 1993 Nov;50(11):1157-63. Review.

PMID:
8215974
10.

Histone post-translational modifications in Huntington's and Parkinson's diseases.

Peña-Altamira LE, Polazzi E, Monti B.

Curr Pharm Des. 2013;19(28):5085-92. Review.

PMID:
23448464
11.

Genetic neurodegenerative diseases: the human illness and transgenic models.

Price DL, Sisodia SS, Borchelt DR.

Science. 1998 Nov 6;282(5391):1079-83. Review.

PMID:
9804539
12.

Yeast as a drug discovery platform in Huntington's and Parkinson's diseases.

Outeiro TF, Giorgini F.

Biotechnol J. 2006 Mar;1(3):258-69. Review.

PMID:
16897706
13.

Genes and the environment in neurodegeneration.

Coppedè F, Mancuso M, Siciliano G, Migliore L, Murri L.

Biosci Rep. 2006 Oct;26(5):341-67. Review.

PMID:
17029001
14.
15.

Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases.

Alexi T, Borlongan CV, Faull RL, Williams CE, Clark RG, Gluckman PD, Hughes PE.

Prog Neurobiol. 2000 Apr;60(5):409-70. Review.

PMID:
10697073
16.

Modelling of Parkinson's disease in mice.

Chesselet MF, Richter F.

Lancet Neurol. 2011 Dec;10(12):1108-18. doi: 10.1016/S1474-4422(11)70227-7. Review.

PMID:
22094131
17.

Animal models of neurodegenerative diseases.

Ribeiro FM, Camargos ER, de Souza LC, Teixeira AL.

Rev Bras Psiquiatr. 2013;35 Suppl 2:S82-91. doi: 10.1590/1516-4446-2013-1157. Review.

18.

Genetic mouse models of neurodegenerative diseases.

Trancikova A, Ramonet D, Moore DJ.

Prog Mol Biol Transl Sci. 2011;100:419-82. doi: 10.1016/B978-0-12-384878-9.00012-1. Review.

PMID:
21377633
19.

Chapter 33: the history of movement disorders.

Lanska DJ.

Handb Clin Neurol. 2010;95:501-46. doi: 10.1016/S0072-9752(08)02133-7. Review.

PMID:
19892136
20.

Effects of chronic MPTP and 3-nitropropionic acid in nonhuman primates.

Brouillet E, Hantraye P.

Curr Opin Neurol. 1995 Dec;8(6):469-73. Review.

PMID:
8845934

Supplemental Content

Support Center